THIS paper is a report on a controlled study of the effects of a new sympathomimetic drug on patients with coronary arteriosclerosis. The drug, l-cyclohexyl-2-methylaminopropane, is used commercially ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback